GAFFX
Price
$88.43
Change
+$0.42 (+0.48%)
Updated
Oct 15 closing price
Net Assets
337.05B
JLGQX
Price
$91.95
Change
+$0.38 (+0.41%)
Updated
Oct 15 closing price
Net Assets
124.35B
Interact to see
Advertisement

GAFFX vs JLGQX

Header iconGAFFX vs JLGQX Comparison
Open Charts GAFFX vs JLGQXBanner chart's image
American Funds Growth Fund of Amer F3
Price$88.43
Change+$0.42 (+0.48%)
VolumeN/A
Net Assets337.05B
JPMorgan Large Cap Growth R4
Price$91.95
Change+$0.38 (+0.41%)
VolumeN/A
Net Assets124.35B
GAFFX vs JLGQX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. JLGQX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Hold and JLGQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 337B vs. JLGQX (124B). GAFFX pays higher dividends than JLGQX: GAFFX (0.58) vs JLGQX (0.00). GAFFX was incepted earlier than JLGQX: GAFFX (9 years) vs JLGQX (9 years). JLGQX (0.75) is less costly to investors than GAFFX (0.30). JLGQX is a more actively managed with annual turnover of: 52.00 vs. GAFFX (25.00). JLGQX has a lower initial minimum investment than GAFFX: JLGQX (0) vs GAFFX (1000000). JLGQX annual gain was more profitable for investors over the last year : 18.32 vs. GAFFX (12.93). JLGQX return over 5 years is better than : 55.22 vs. GAFFX (42.45).
GAFFXJLGQXGAFFX / JLGQX
Total Expense Ratio0.300.6943%
Annual Report Gross Expense Ratio0.300.7540%
Fund Existence9 years9 years-
Gain YTD18.74615.153124%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets337B124B272%
Annual Yield % from dividends0.580.00-
Returns for 1 year12.9318.3271%
Returns for 3 years81.59107.1476%
Returns for 5 years42.4555.2277%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV1.890.15
+8.62%
Acrivon Therapeutics
LTC34.670.46
+1.34%
LTC Properties
SAR22.170.02
+0.09%
SARATOGA INVESTMENT Corp
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
AGCO107.01-0.14
-0.13%
AGCO Corp